[1]刘纯岳,林帝金,方俊粤,等.健康成年人血清α-L-岩藻糖苷酶参考区间的建立及适用性评价[J].现代检验医学杂志,2018,33(05):102-104+107.[doi:10.3969/j.issn.1671-7414.2018.05.027]
　LIU Chun-yue,LIN Di-jin,FANG Jun-yue,et al.Establishment and Applicability Evaluation of Reference Interval for Serum AFU of Healthy Adults[J].Journal of Modern Laboratory Medicine,2018,33(05):102-104+107.[doi:10.3969/j.issn.1671-7414.2018.05.027]
点击复制

健康成年人血清α-L-岩藻糖苷酶参考区间的建立及适用性评价()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第33卷
期数:
2018年05期
页码:
102-104+107
栏目:
论著
出版日期:
2018-11-18

文章信息/Info

Title:
Establishment and Applicability Evaluation of Reference Interval for Serum AFU of Healthy Adults
文章编号:
1671-7414(2018)05-102-04
作者:
刘纯岳1; 林帝金1; 方俊粤1; 梁洁满2; 劳伟思1; 林向华1
1.中山大学孙逸仙纪念医院检验科, 广州 510120; 2.广州医科大学附属第二医院检验科,广州 510220
Author(s):
LIU Chun-yue1; LIN Di-jin1; FANG Jun-yue1; LIANG Jie-man2; LAO Wei-si1; LIN Xiang-hua1
1.Department of Clinical Laboratory,Sun Yat-Sen Memorial Hospital,Sun Yat-Sen University, Guangzhou 510120,China; 2.Department of Clinical Laboratory,the Second Affiliated Hospital of Guangzhou Medical University,Guangzhou 510220,China
关键词:
健康成年人;  α-L-岩藻糖苷酶;  参考区间;  适用性
分类号:
R446.112
DOI:
10.3969/j.issn.1671-7414.2018.05.027
文献标志码:
A
摘要:
目的 建立健康成年人血清α-L-岩藻糖苷酶(α-L-fucosidase,AFU)参考区间,并对AFU的临床适用性进行评价。方法 收集中山大学孙逸仙纪念医院2017年4～10月480例健康成年体检者,其中按性别分为男性组240例,女性组240例; 按年龄分为青年组(18～44岁)160例、中年组(45～59岁)160例和老年组(≥60岁)160例,各个年龄组再按性别分组。同时收集确诊为原发性肝癌的患者119例作为病例组,其中男性91例,女性28例,年龄24～82岁,采用CNPF底物法测定其血清AFU结果,并对数据进行统计学分析。结果 男性组、女性组、青年组、中年组、老年组、青年男性组、青年女性组、中年男性组、中年女性组、老年男性组和老年女性组的AFU水平分别为26.39±6.55,25.23±6.31,24.18±5.78,26.80±6.79,26.47±6.47,24.84±5.56,23.53±5.96,27.29±7.18,26.27±6.38,27.03±6.62和25.91±6.31 U/L。不同年龄及性别间血清AFU水平的差异均无统计学意义(P>0.05)。健康成年人血清AFU的单一参考区间为13～38 U/L。用此区间评估原发性肝癌患者的灵敏度为83.2%,特异度为94.1%。结论 通过研究建立了健康成年人血清AFU的参考区间,为临床原发性肝癌的诊断和治疗提供了更加准确的实验依据。AFU在肝病患者中具有较高的临床适用价值。
Abstract:
Objective To establish the reference interval of serum α-L-fucosidase(AFU)in healthy adults and evaluate the clinical application of AFU.Methods A total of 480 healthy adult physical examinees from April to October 2017 in Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University were Collected.There were 240 males and 240 females by sex.They were divided into youth group(18～44 years old)160 cases,middle age group(45～59 years old)160 cases and elderly group(60 years old or above 60 years old)160 caces according to age.At the same time,119 cases of primary livercancer were collected as case group,including 91 males,28 women and 24～82 years old.The results of serum AFU were measured by CNPF substrate method, and the data were statistically analyzed.Results AFU levels ofthe male group,the young group,the middle-aged group,the elderly group,theyoung male group,the young female group,the middle-aged male group,the middle-aged female group,the elderly male group and the elderly female group were26.39±6.55,25.23±6.31,24.18±5.78,26.80±6.79,26.47±6.47,24.84±5.56,23.53±5.96,27.29±7.18,26.27±6.38,27.03±6.62 and 25.91±6.31 U/L,respectively.There was no significant difference in serum AFU levels between different ages and sex(P>0.05).The single reference interval of serum AFU in healthy adults ranged from 13U/L to 38 U/L.The sensitivity andspecificity of this interval for primary liver cancer patients were 83.2% and 94.1% respectively.Conclusion The reference interval ofserum AFU in healthy adults has been established through research,providing more accurate experimental evidence for clinical diagnosis and treatment of primaryliver cancer.In a word,AFU has a better clinical application in hepatopathy.

参考文献/References:

[1] 杨 沛,贾喻惠,蔡晓娜,等.血清α-L-岩藻糖苷酶对原发性肝癌的诊断价值[J].国际检验医学杂志,2016,37(24):3467-3468.
Yang P,Jia YH,Cai XN,et al.The value of serum α-L-fucosidaseactivity in the diagnosis of primary hepatic carcinoma[J].International Journal of Laboratory Medicine,2016,37(24):3467-3468.
[2] International Organization for Standardization.ISO15 189:2012 Medical Laboratories:Requirements for Quality and Competence[S].Switzerland:Geneva,IS015189,2012.
[3] 李 鹏,葛 淼,王聪霞,等.肿瘤因子α-L-岩藻糖苷酶参考值的空间分布规律[J].中山大学学报(医学科学版),2017,38(3):459-467.
Li P,Ge M,Wang CX,et al.Spatial variation of reference value oftumor biomarker:Alpha-L-Fucosidase[J].Journal of Sun Yat-sen University(Medical Sciences),2017,38(3):459-467.
[4] Clinical and Laboratory Standards Institute.CLSI EP 28-A3C Defining,establishing,and verifying reference intervals in the clinical laboratory; approved guideline-third edition[R].Wayne:PA,CLSI EP28-A3C 2010.
[5] 中华人民共和国国家卫生和计划生育委员会.WS/T 402.2012:临床实验室检验项目参考区间的制定[S].北京:中国标准出版社,2013.
National Health and Family Planning Commission of the People's Republic of China.WS/T 402.2012:Define and determine the reference intervals in Clinical laboratory[S].Beijing:China Standard Press,2013.
[6] 郭 健,蒋 琳.参考区间与医学检验[J].中华检验医学杂志,2008,31(11):1316-1319.
Guo J,Jiang L.Reference interval and Medical examination[J].Chinese Journal of Laboratory Medicine,2008,31(11):1316-1319.
[7] 中华人民共和国卫生部.原发性肝癌诊疗规范(2011年版)[J].临床肝胆病杂志,2011,27(11):1141-1159.
Ministry of Health,PRC.Diagnosis management,and treatment of hepatocellular carcinomal(2011)[J].J Clin Hepatol,2011,27(11):1141-1159.
[8] 徐伟红,姚怡婷,曹 华,等.血清GP73,AFP-L3,AFP及AFU检测在原发性肝癌诊断中的应用评价[J].中华检验医学杂志,2016,39(4):262-266.
Xu WH,Yao YT,Cao H,et al.Assessment of serum GP73,AFP-L3,AFPand AFU detection in the diagnosis of hepatocellular carcinoma[J].Chinese Journal of Laboratory Medicine,2016,39(4):262-266.
[9] 曾 洁,陈文祥,申子瑜.参考区间研究现状概述[J].中华检验医学杂志,2010,33(6):570-573.
Zeng J,Chen WX,Shen ZY.A Survey of the status quo of reference interval research[J].Chinese Journal of Laboratory Medicine,2010,33(6):570-573.
[10] 尚 红,王毓三,申子瑜,等.全国临床检验操作规程[S].4版.北京:人民卫生出版社,2014:295-296.
Shang H,Wang YS,Shen ZY,et al.National practice for clinical testing[S].4th Ed.Beijing:People's Health Publishing House,2014:295-296.

相似文献/References:

[1]李爽爽,王志成.应用UPLC-MS/MS 检测上海市成年健康人群血清维生素B6 和B7 参考区间的建立[J].现代检验医学杂志,2022,37(06):140.[doi:10.3969/j.issn.1671-7414.2022.06.026]
　LI Shuang-shuang,WANG Zhi-cheng.Establishment of Reference Intervals for Serum Vitamin B6 and B7 in Healthy Adults in Shanghai by UPLC-MS/MS[J].Journal of Modern Laboratory Medicine,2022,37(05):140.[doi:10.3969/j.issn.1671-7414.2022.06.026]

备注/Memo

备注/Memo:
作者简介:刘纯岳(1986-),男,本科,检验技师,主要从事生物化学方面的工作及研究,E-mail:738703822@qq.com。
通讯作者:林向华,E-mail:13826068632@163.com。
更新日期/Last Update: 2018-09-30